Shire Unit Settles Genzyme False Advertising Suit

Law360, New York (February 25, 2014, 7:03 PM EST) -- A Massachusetts federal judge on Tuesday pulled the plug on a Genzyme Corp. suit accusing Shire Human Genetic Therapies Inc. of misleading consumers by advertising its genetic disease drug VPRIV as superior to Genzyme's Cerezyme after both parties said they'd reached a settlement.

U.S. District Judge Richard G. Stearns signed off on a consent order drafted by both parties ending the litigation on the condition that Shire agree to never again to distribute a press release from June 2012 that touted research findings in a way...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.